Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Santa Rosa › NPI 1134152549
Hospital

ST. Joseph Health Northern California, LLC

ST. Joseph Health Northern California, LLC was paid $48.75M by Medicaid between Jan 2018 and Nov 2024, across 305 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoST. JOSEPH HEALTH NORTHERN CALIFORNIA, LLC
SANTA ROSA, CA 95405
33aNPI1134152549assigned 07/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$48.75M
24GClaims1,000,294
24DCodes billed305
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#62 of 410
Median peer was paid$6.90M
This provider vs. median7.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018151,115$8.10M
2019141,646$6.38M
2020118,219$5.71M
2021129,722$6.06M
2022154,349$7.54M
2023172,621$8.43M
2024incomplete132,622$6.54M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 89,593 74,451 $6.91M
99281 Emergency department visit for the evaluation and management, self-limited or minor 9.1% 55,376 46,885 $4.44M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 5.0% 35,311 32,071 $2.42M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.5% 6,375 6,171 $2.18M
99201 4.2% 29,139 25,309 $2.06M
70450 Computed tomography, head or brain; without contrast material 2.9% 7,219 6,859 $1.40M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.3% 13,745 12,733 $1.10M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 13,086 11,936 $1.09M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.0% 7,068 6,505 $984K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 20,664 5,403 $967K
71260 Computed tomography, thorax, diagnostic; with contrast material 2.0% 2,448 2,388 $961K
72125 Computed tomography, cervical spine; without contrast material 2.0% 3,032 2,922 $954K
293 more codes
97139 1.6% 17,115 $803K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1.6% 1,919 $774K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.6% 1,137 $774K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 18,252 $698K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1.4% 1,914 $677K
96375 Therapeutic injection; each additional sequential IV push 1.4% 13,170 $671K
78815 Positron emission tomography (PET) for limited area imaging 1.3% 240 $611K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 5,714 $602K
J3490 Unclassified drugs 1.2% 94,899 $580K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.2% 3,052 $567K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,153 $453K
93975 <1% 1,542 $439K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,731 $435K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,906 $431K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,948 $425K
J9271 Injection, pembrolizumab, 1 mg <1% 30 $379K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 49,281 $356K
J2704 Injection, propofol, 10 mg <1% 8,981 $349K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,343 $347K
97750 <1% 3,876 $329K
80053 Comprehensive metabolic panel <1% 33,224 $320K
96361 Intravenous infusion, hydration; each additional hour <1% 8,165 $311K
95811 <1% 899 $308K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,735 $307K
73221 <1% 762 $302K
72141 <1% 804 $302K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,020 $288K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,972 $266K
71045 Radiologic examination, chest; single view <1% 15,813 $261K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,543 $259K
97010 <1% 5,793 $257K
76830 Ultrasound, transvaginal <1% 2,652 $253K
0450 Emergency room services <1% 1,157 $247K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 4,986 $241K
71250 <1% 951 $218K
71275 Computed tomographic angiography, chest, with contrast material <1% 644 $205K
71046 Radiologic examination, chest; 2 views <1% 7,330 $201K
97799 <1% 4,587 $199K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,362 $198K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,793 $194K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 15,684 $189K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,584 $184K
76770 <1% 1,792 $180K
93971 <1% 1,148 $177K
70486 <1% 720 $171K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,892 $157K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,806 $155K
83880 <1% 4,657 $150K
G9012 Other specified case management service not elsewhere classified <1% 410 $144K
J0185 Injection, aprepitant, 1 mg <1% 466 $135K
J2505 Injection, pegfilgrastim, 6 mg <1% 18 $134K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,419 $128K
72100 <1% 2,778 $118K
73610 <1% 2,954 $118K
73630 <1% 3,236 $117K
73030 <1% 2,938 $115K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,772 $113K
Z7502 <1% 2,917 $110K
77334 <1% 349 $110K
80048 Basic metabolic panel (calcium, ionized) <1% 13,714 $106K
90715 <1% 1,928 $99K
73130 <1% 2,574 $98K
93970 <1% 371 $97K
87631 <1% 883 $95K
73562 <1% 2,621 $92K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,342 $92K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 263 $89K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,879 $82K
84484 <1% 9,338 $81K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,820 $80K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 10,128 $77K
76536 <1% 966 $74K
99152 <1% 1,028 $73K
83690 <1% 11,764 $72K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,405 $72K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,404 $71K
73110 <1% 1,807 $70K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 281 $70K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,130 $68K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,286 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,928 $66K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,598 $65K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,353 $64K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 6,388 $62K
74018 <1% 2,221 $59K
73560 <1% 2,197 $58K
76642 <1% 745 $58K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 154 $58K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 123 $57K
J0690 Injection, cefazolin sodium, 500 mg <1% 4,695 $57K
96367 <1% 956 $57K
96417 <1% 1,014 $56K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 616 $55K
83605 <1% 5,249 $53K
73502 <1% 1,270 $53K
81001 <1% 14,434 $51K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 983 $50K
72040 <1% 1,385 $50K
93017 <1% 412 $50K
J2785 Injection, regadenoson, 0.1 mg <1% 205 $50K
80306 <1% 1,970 $46K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,821 $44K
96415 <1% 858 $44K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,788 $41K
87040 <1% 3,958 $41K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,498 $37K
99070 <1% 2,132 $37K
95816 <1% 498 $36K
87070 <1% 4,927 $36K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 1,101 $36K
73140 <1% 1,435 $35K
80076 <1% 4,888 $33K
J1644 Injection, heparin sodium, per 1000 units <1% 2,616 $33K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 232 $32K
J1756 Injection, iron sucrose, 1 mg <1% 654 $32K
J3480 Injection, potassium chloride, per 2 meq <1% 662 $32K
87186 <1% 3,575 $32K
87077 <1% 3,926 $32K
70496 <1% 123 $31K
76801 <1% 407 $31K
84443 Thyroid stimulating hormone (TSH) <1% 2,185 $30K
85055 <1% 1,220 $28K
59025 Fetal non-stress test <1% 829 $28K
76870 <1% 363 $28K
70498 <1% 114 $28K
10060 <1% 775 $28K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 423 $27K
85610 <1% 6,949 $25K
72170 <1% 814 $25K
97164 <1% 267 $24K
72110 <1% 360 $23K
Z7500 <1% 639 $22K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,134 $21K
97165 <1% 249 $21K
Z7610 <1% 1,883 $20K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,716 $20K
81003 <1% 8,397 $20K
J2060 Injection, lorazepam, 2 mg <1% 2,624 $20K
73080 <1% 462 $19K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 355 $18K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 231 $18K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 734 $18K
77336 <1% 162 $18K
12001 <1% 616 $17K
81025 <1% 4,865 $17K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 861 $16K
77300 <1% 71 $16K
73090 <1% 486 $15K
82962 <1% 5,030 $15K
73590 <1% 480 $15K
J1815 Injection, insulin, per 5 units <1% 473 $15K
83735 <1% 2,380 $14K
93976 <1% 50 $14K
G0202 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed <1% 76 $14K
85730 <1% 2,348 $13K
86901 <1% 3,885 $13K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 438 $13K
86900 <1% 3,865 $13K
83615 <1% 1,832 $12K
84145 <1% 651 $12K
77080 <1% 242 $11K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,836 $11K
87075 <1% 1,286 $11K
86850 <1% 3,215 $10K
77066 Tomosynthesis, mammo <1% 65 $10K
80047 <1% 836 $10K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 569 $10K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 275 $9K
85027 <1% 1,663 $8K
85379 <1% 887 $8K
73564 <1% 191 $7K
72197 <1% 17 $7K
99153 Mod sedat endo service >5yrs <1% 409 $7K
87205 <1% 1,975 $7K
J3475 Injection, magnesium sulfate, per 500 mg <1% 691 $7K
87634 <1% 127 $6K
81002 <1% 3,132 $6K
G0400 Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels <1% 106 $6K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 195 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 635 $6K
J0640 Injection, leucovorin calcium, per 50 mg <1% 37 $6K
12011 <1% 135 $6K
71271 <1% 44 $6K
J3370 Injection, vancomycin hcl, 500 mg <1% 437 $6K
86140 <1% 1,100 $5K
96368 <1% 189 $5K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 173 $5K
76999 <1% 42 $5K
74183 <1% 12 $5K
99199 Unlisted special service, procedure or report <1% 120 $5K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 135 $5K
88342 <1% 408 $5K
12002 <1% 174 $5K
29125 <1% 375 $5K
99284 Emergency room visit (serious) <1% 16 $5K
70491 <1% 13 $5K
82077 <1% 326 $5K
86141 <1% 436 $5K
77081 <1% 177 $5K
73700 <1% 15 $4K
76827 <1% 57 $4K
88304 <1% 493 $4K
96416 <1% 44 $4K
96523 <1% 288 $4K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 65 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 562 $4K
72146 <1% 12 $3K
J9190 Injection, fluorouracil, 500 mg <1% 52 $3K
87081 <1% 668 $3K
87147 <1% 618 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 25 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 464 $3K
72070 <1% 67 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 347 $3K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 30 $3K
93880 <1% 13 $2K
82248 <1% 610 $2K
29823 <1% 12 $2K
96402 <1% 117 $2K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 61 $2K
85652 <1% 627 $2K
82803 <1% 185 $2K
73070 <1% 66 $2K
80143 <1% 117 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 79 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 158 $2K
82728 <1% 134 $2K
73620 <1% 69 $2K
80061 Lipid panel <1% 216 $2K
S0077 Injection, clindamycin phosphate, 300 mg <1% 97 $2K
80179 <1% 115 $2K
85018 <1% 773 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 71 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 395 $2K
82805 <1% 75 $2K
29515 <1% 105 $1K
0270 <1% 34 $1K
82550 <1% 207 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 43 $1K
96411 <1% 35 $1K
84702 <1% 123 $1K
J3489 Injection, zoledronic acid, 1 mg <1% 12 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 50 $1K
0456 <1% 39 $1K
73600 <1% 39 $1K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 16 $996.18
84439 <1% 159 $972.84
J0360 Injection, hydralazine hcl, up to 20 mg <1% 69 $956.91
82140 <1% 72 $940.88
73660 <1% 39 $910.50
73060 <1% 28 $895.44
72081 <1% 25 $882.74
84466 <1% 54 $867.19
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 58 $826.46
94729 <1% 12 $820.68
J7120 Ringers lactate infusion, up to 1000 cc <1% 108 $770.72
94726 <1% 12 $752.16
76882 <1% 47 $686.80
72050 <1% 14 $643.80
86923 <1% 14 $616.00
29130 <1% 41 $615.34
71010 <1% 30 $602.31
29505 <1% 39 $548.21
85014 <1% 202 $530.88
73521 <1% 13 $508.08
83540 <1% 67 $507.73
73120 <1% 18 $464.40
88142 <1% 51 $438.25
84132 <1% 108 $436.86
84100 <1% 133 $424.96
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 81 $367.47
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 80 $352.34
73565 <1% 14 $351.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 55 $328.61
73100 <1% 13 $324.36
J1953 Injection, levetiracetam, 10 mg <1% 19 $302.66
84703 <1% 56 $297.25
S0164 Injection, pantoprazole sodium, 40 mg <1% 23 $245.68
J1171 Injection, hydromorphone, 0.1 mg <1% 31 $223.25
82378 <1% 16 $194.08
J1650 Injection, enoxaparin sodium, 10 mg <1% 30 $188.21
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 638 $175.38
J1940 Injection, furosemide, up to 20 mg <1% 29 $163.44
82746 <1% 12 $128.13
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 16 $114.13
J8540 Dexamethasone, oral, 0.25 mg <1% 1,100 $110.89
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,480 $107.90
87210 <1% 12 $81.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 14 $69.02
86308 <1% 13 $46.67
88300 <1% 17 $28.39
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 649 $23.45
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 72 $5.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS)
Parent organizationST JOSEPH HEALTH SYSTEM
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.